Company: ANIX
Filing Date: 2025-05-28
Form Type: 10-Q
Source: 0001641172-25-012701
Chunk: 28

Company: Anixa Biosciences Inc
Filing Date: 2025-05-28
Form: 10-Q
Item: Part I, Item 8
Chunk 28
---
28, 2025.

    101.INS
    Inline XBRL Instance Document

    101.SCH
    Inline XBRL Taxonomy Extension Schema

    101.CAL
    Inline XBRL Taxonomy Extension Calculation Linkbase

    101.DEF
    Inline XBRL Taxonomy Extension Definition Linkbase

    101.LAB
    Inline XBRL Taxonomy Extension Label Linkbase

    101.PRE
    Inline XBRL Taxonomy Extension Presentation Linkbase

    104
    Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)

22

SIGNATURES

Pursuant to the requirements of
the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.

    ANIXA BIOSCIENCES, INC.

    By:
    /s/ Dr. Amit Kumar

    Dr. Amit Kumar

    Chairman and Chief Executive Officer 
  
    May 28, 2025
     
    (Principal Executive Officer)

    By:
    /s/ Michael J. Catelani

    Michael J. Catelani

    President, Chief Operating Officer and 

    Chief Financial Officer

    (Principal Financial and
  
    May 28, 2025
     
    Accounting Officer)

23